MedPath

A Physical Activity Program in End-state Liver Disease

Not Applicable
Completed
Conditions
Liver Transplant
Sarcopenia
End-stage Liver Disease (ESLD)
Poor Physical Fitness
Cirrhosis
Portal Hypertension
Interventions
Other: Nutritional consultation
Behavioral: Physical training program
Behavioral: Behavioral modification therapy
Registration Number
NCT02776553
Lead Sponsor
University of Arkansas
Brief Summary

The primary aim of this study is to improve both physical fitness and sarcopenia of patients with ESLD who are potentially eligible for liver transplantation through a 12-week physical training program. Secondary aims will focus on changes in anthropometrics, body composition, quality of life, and metabolic profile. This is a randomized clinical trial including 50 patients, with half allocated to the active group (physical training program) and half to standard of care.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Age 40 to 70.

  • Cirrhosis, any cause, defined as:

    • Biopsy-proven.
    • Two or more of the following: albumin <3.5 g/dL, International Normalized Ration (INR) >1.3, radiologic or endoscopic evidence of portal hypertension.
  • Creatinine <2.0 mg/dL.

  • Physiologic Model for End Stage Liver Disease (MELD) ≥10.

  • Decompensated cirrhosis with active or history of variceal bleeding, ascites, hepatic encephalopathy, or jaundice.

  • Potential transplant candidate as per UAMS criteria

Exclusion Criteria
  • Large gastric or esophageal varices with contraindication to use beta-blockers.
  • Persistent hepatic encephalopathy grades 2-4.
  • Prior diagnosis of hepatocellular carcinoma, or hepatic hydrothorax (with prior repeated thoracocentesis).
  • Cirrhotic cardiomyopathy or congestive heart failure, pulmonary vascular complications, known active coronary artery disease, syncope, and cardiac dysrhythmias.
  • Physical impediment to perform a cardiorespiratory fitness test.
  • Use of implantable defibrillator or a pacemaker.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlNutritional consultationnutritional intervention
Active (physical training program)Nutritional consultationphysical activity + behavioral therapy + nutritional intervention
Active (physical training program)Behavioral modification therapyphysical activity + behavioral therapy + nutritional intervention
Active (physical training program)Physical training programphysical activity + behavioral therapy + nutritional intervention
Primary Outcome Measures
NameTimeMethod
SarcopeniaChange from Baseline to 12 weeks after baseline

Total thigh muscle volume (cm\^3), as determined by CT-scan.

Physical Fitness - Distance WalkedChange from Baseline to 12 weeks after baseline

Total distance walked during 6-minute walk test

Physical Fitness - VO2Change from Baseline to 12 weeks after baseline

Peak VO2 will be obtained from cardiorespiratory stress test

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath